サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1578296

自己細胞療法の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2024年～2032年の予測

Global Autologous Cell Therapy Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日
ページ情報
英文 128 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=147.05円
自己細胞療法の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2024年～2032年の予測
出版日: 2024年09月01日
発行: Value Market Research
ページ情報: 英文 128 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

自己細胞療法市場の世界需要は、2023年の48億6,000万米ドルから2032年には307億1,000万米ドル近くの市場規模に達すると推定され、調査期間2024-2032年のCAGRは22.74%です。

自己細胞療法（ACT）は、個人の細胞を利用して様々な病気を治療する新しい治療法です。患者の細胞を体外で培養し、体外で細胞数を増やして再び体内に戻します。この治療法は、副作用の軽減、生体不適合、移植に伴う疾患トランスミッション、全身的な免疫反応や疾患のリスクの軽減を保証します。この治療法には、自家幹細胞療法と自家細胞免疫療法の2種類があります。自己幹細胞療法は、骨髄表皮や他の供給源から採取した細胞を培養・増殖します。自己幹細胞療法は、がん、筋骨格系疾患、血液疾患、美容治療などに応用されています。病院や研究センターでは、患者を治療するために自家療法の使用を増やしています。

市場力学

がん、神経疾患、自己免疫疾患の有病率の増加が、自家療法市場を牽引している主な要因です。副作用の軽減や他の病気へのトランスミッションのリスク軽減といった要因が市場を活性化しています。さらに、細胞培養におけるR&Dの増加や、新規の革新的治療における政府の取り組みが、世界市場を押し上げています。COVID-19の世界的大流行中、自己細胞療法市場は、細胞培養療法のR&Dの高まりとともに、ヘルスケア市場全体の成長により、安定的ではあるが傾斜成長が期待されています。

この調査レポートは、ポーターのファイブフォースモデル、市場の魅力分析、バリューチェーン分析をカバーしています。これらのツールは、業界の構造を明確に把握し、世界レベルでの競合の魅力を評価するのに役立ちます。さらに、これらのツールは、自己細胞療法の世界市場における各セグメントを包括的に評価することもできます。自己細胞療法産業の成長と動向は、この調査に全体的なアプローチを提供します。

カスタム要件がある場合は、お問い合わせください。当社の調査チームは、お客様のニーズに応じてカスタマイズしたレポートを提供することができます。

目次

第1章 序文

第2章 エグゼクティブサマリー

  • 市場のハイライト
  • 世界市場スナップショット

第3章 自己細胞療法- 産業分析

  • イントロダクション：市場力学
  • 市場促進要因
  • 市場抑制要因
  • 機会
  • 業界動向
  • ポーターのファイブフォース分析
  • 市場の魅力分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原材料分析
    • 原材料リスト
    • 原材料メーカーリスト
    • 主要原材料の価格動向
  • 潜在的バイヤーのリスト
  • マーケティングチャネル
    • ダイレクトマーケティング
    • インダイレクトマーケティング
    • マーケティングチャネル発展動向

第5章 自己細胞療法の世界市場分析：用途別

  • 概要
  • 実績および予測データ分析
  • がん
  • 神経変性疾患
  • 心血管疾患
  • 自己免疫疾患
  • 整形外科
  • 創傷治癒
  • その他

第6章 自己細胞療法の世界市場分析：供給源別

  • 概要
  • 実績および予測データ分析
  • 骨髄
  • 表皮
  • 間葉系幹細胞
  • 造血幹細胞
  • 軟骨細胞
  • その他

第7章 自己細胞療法の世界市場分析：最終用途別

  • 概要
  • 実績および予測データ分析
  • 病院・クリニック
  • 外来センター
  • 大学・研究機関
  • その他

第8章 自己細胞療法の世界市場分析：地域別

  • 地域別展望
  • イントロダクション
  • 北米売上分析
    • 概要、実績と予測
    • 北米：セグメント別
    • 北米国別
    • 米国
    • カナダ
    • メキシコ
  • 欧州売上分析
    • 概要、実績と予測
    • 欧州セグメント別
    • 欧州国別
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • ロシア
    • その他欧州
  • アジア太平洋地域売上分析
    • 概要、実績と予測
    • アジア太平洋地域セグメント別
    • アジア太平洋地域国別
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • 東南アジア
    • その他アジア太平洋地域
  • ラテンアメリカ売上分析
    • 概要、実績と予測
    • ラテンアメリカ：セグメント別
    • ラテンアメリカ国別
    • ブラジル
    • アルゼンチン
    • ペルー
    • チリ
    • その他ラテンアメリカ
  • 中東・アフリカ売上分析
    • 概要、実績と予測
    • 中東・アフリカセグメント別
    • 中東・アフリカ国別一覧
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他中東とアフリカ

第9章 自己細胞療法企業の競合情勢

  • 自己細胞療法市場の競合
  • 提携・協力・合意
  • 合併・買収
  • 新製品の上市
  • その他の開発

第10章 企業プロファイル

  • 上位企業の市場シェア分析
  • 市場集中度
  • BrainStorm Cell Therapeutics
  • Holostem Terapie Avanzate S.R.L
  • Sartorius AG
  • Pharmicell Co. Inc
  • Opexa Therapeutics
  • Caladrius Biosciences Inc
  • U.S. Stem Cell Inc
  • Lonza
  • Bristol Myers Squibb
  • Novartis
  • Autolus Therapeutics
  • Tego Science
  • Corning Incorporated
  • Bio Elpida
  • Vericel Corporation
  • Catalent Inc
図表

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Application (USD MN)
  • Cancer Market Sales By Geography (USD MN)
  • Neurodegenerative Disorders Market Sales By Geography (USD MN)
  • Cardiovascular Disorders Market Sales By Geography (USD MN)
  • Autoimmune Disorders Market Sales By Geography (USD MN)
  • Orthopedics Market Sales By Geography (USD MN)
  • Wound Healing Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Analysis By Source (USD MN)
  • Bone Marrow Market Sales By Geography (USD MN)
  • Epidermis Market Sales By Geography (USD MN)
  • Mesenchymal Stem Cells Market Sales By Geography (USD MN)
  • Haematopoietic Stem Cells Market Sales By Geography (USD MN)
  • Chondrocytes Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Analysis By End-use (USD MN)
  • Hospitals & Clinics Market Sales By Geography (USD MN)
  • Ambulatory Centers Market Sales By Geography (USD MN)
  • Academics & Research Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Autologous Cell Therapy Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Autologous Cell Therapy Report
  • Market Research Process
  • Market Research Methodology
  • Global Autologous Cell Therapy Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Application
  • Market Attractiveness Analysis By Source
  • Market Attractiveness Analysis By End-use
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Application (USD MN)
  • Cancer Market Sales By Geography (USD MN)
  • Neurodegenerative Disorders Market Sales By Geography (USD MN)
  • Cardiovascular Disorders Market Sales By Geography (USD MN)
  • Autoimmune Disorders Market Sales By Geography (USD MN)
  • Orthopedics Market Sales By Geography (USD MN)
  • Wound Healing Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Analysis By Source (USD MN)
  • Bone Marrow Market Sales By Geography (USD MN)
  • Epidermis Market Sales By Geography (USD MN)
  • Mesenchymal Stem Cells Market Sales By Geography (USD MN)
  • Haematopoietic Stem Cells Market Sales By Geography (USD MN)
  • Chondrocytes Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Analysis By End-use (USD MN)
  • Hospitals & Clinics Market Sales By Geography (USD MN)
  • Ambulatory Centers Market Sales By Geography (USD MN)
  • Academics & Research Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

目次
Product Code: VMR11212590

The global demand for Autologous Cell Therapy Market is presumed to reach the market size of nearly USD 30.71 Billion by 2032 from USD 4.86 Billion in 2023 with a CAGR of 22.74% under the study period 2024-2032.

Autologous cell therapy (ACT) is a novel therapy that uses an individual's cells to treat various diseases. The therapy utilizes the patient's cells, which are cultured outside the body, the cell number is expanded in-vitro and reintroduced to the body. The therapy assures reduced side effects, reduced the risk of bio-incompatibility, disease transmission associated with graft, and systemic immunological reactions and disease. The therapy can be of two types; autologous stem cell therapy and autologous cellular immune therapies. The cells from bone marrow epidermis or other sources are utilized for cell culture and expansion. Autologous therapy is applied in the treatment of cancers, musculoskeletal disorders, blood disorders, and cosmetic treatments. Hospitals and research centers are increasing the use of autologous therapy to treat patients.

MARKET DYNAMICS

The growing prevalence of cancer, neurological disorders, and autoimmune diseases are the prime factors that are driving the autologous therapy market. The factors such as reduced side effects and reduced risk of transmission of other diseases are fuelling the market. Moreover, increasing R & D in cell culture, and government initiatives in novel innovative therapies is uplifting the global market. During the global pandemic COVID-19, the autologous therapy market is expected to experience steady but inclining growth owing to the growing overall healthcare market along with rising R & D in cell culture therapies.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Autologous Cell Therapy. The growth and trends of Autologous Cell Therapy industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Autologous Cell Therapy market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Application

  • Cancer
  • Neurodegenerative Disorders
  • Cardiovascular Disorders
  • Autoimmune Disorders
  • Orthopedics
  • Wound Healing
  • Others

By Source

  • Bone Marrow
  • Epidermis
  • Mesenchymal Stem Cells
  • Haematopoietic Stem Cells
  • Chondrocytes
  • Others

By End-use

  • Hospitals & Clinics
  • Ambulatory Centers
  • Academics & Research
  • Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Autologous Cell Therapy market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Autologous Cell Therapy market include BrainStorm Cell Therapeutics, Holostem Terapie Avanzate, S.R.L, Pharmicell Co. Inc, Opexa Therapeutics, Caladrius Biosciences Inc, U.S. Stem Cell Inc, Lonza, Bristol Myers Squibb, Novartis, Autolus Therapeutics, Tego Science, Corning Incorporated, Bio Elpida, Vericel Corporation, Catalent Inc, Sartorius AG. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. AUTOLOGOUS CELL THERAPY - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Application
    • 3.7.2 Market Attractiveness Analysis By Source
    • 3.7.3 Market Attractiveness Analysis By End-use
    • 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL AUTOLOGOUS CELL THERAPY MARKET ANALYSIS BY APPLICATION

  • 5.1. Overview By Application
  • 5.2. Historical and Forecast Data Analysis By Application
  • 5.3. Cancer Historic and Forecast Sales By Regions
  • 5.4. Neurodegenerative Disorders Historic and Forecast Sales By Regions
  • 5.5. Cardiovascular Disorders Historic and Forecast Sales By Regions
  • 5.6. Autoimmune Disorders Historic and Forecast Sales By Regions
  • 5.7. Orthopedics Historic and Forecast Sales By Regions
  • 5.8. Wound Healing Historic and Forecast Sales By Regions
  • 5.9. Others Historic and Forecast Sales By Regions

6. GLOBAL AUTOLOGOUS CELL THERAPY MARKET ANALYSIS BY SOURCE

  • 6.1. Overview By Source
  • 6.2. Historical and Forecast Data Analysis By Source
  • 6.3. Bone Marrow Historic and Forecast Sales By Regions
  • 6.4. Epidermis Historic and Forecast Sales By Regions
  • 6.5. Mesenchymal Stem Cells Historic and Forecast Sales By Regions
  • 6.6. Haematopoietic Stem Cells Historic and Forecast Sales By Regions
  • 6.7. Chondrocytes Historic and Forecast Sales By Regions
  • 6.8. Others Historic and Forecast Sales By Regions

7. GLOBAL AUTOLOGOUS CELL THERAPY MARKET ANALYSIS BY END-USE

  • 7.1. Overview By End-use
  • 7.2. Historical and Forecast Data Analysis By End-use
  • 7.3. Hospitals & Clinics Historic and Forecast Sales By Regions
  • 7.4. Ambulatory Centers Historic and Forecast Sales By Regions
  • 7.5. Academics & Research Historic and Forecast Sales By Regions
  • 7.6. Others Historic and Forecast Sales By Regions

8. GLOBAL AUTOLOGOUS CELL THERAPY MARKET ANALYSIS BY GEOGRAPHY

  • 8.1. Regional Outlook
  • 8.2. Introduction
  • 8.3. North America Sales Analysis
    • 8.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.3.2 North America By Segment Sales Analysis
    • 8.3.3 North America By Country Sales Analysis
    • 8.3.4 United States Sales Analysis
    • 8.3.5 Canada Sales Analysis
    • 8.3.6 Mexico Sales Analysis
  • 8.4. Europe Sales Analysis
    • 8.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.4.2 Europe By Segment Sales Analysis
    • 8.4.3 Europe By Country Sales Analysis
    • 8.4.4 United Kingdom Sales Analysis
    • 8.4.5 France Sales Analysis
    • 8.4.6 Germany Sales Analysis
    • 8.4.7 Italy Sales Analysis
    • 8.4.8 Russia Sales Analysis
    • 8.4.9 Rest Of Europe Sales Analysis
  • 8.5. Asia Pacific Sales Analysis
    • 8.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.5.2 Asia Pacific By Segment Sales Analysis
    • 8.5.3 Asia Pacific By Country Sales Analysis
    • 8.5.4 China Sales Analysis
    • 8.5.5 India Sales Analysis
    • 8.5.6 Japan Sales Analysis
    • 8.5.7 South Korea Sales Analysis
    • 8.5.8 Australia Sales Analysis
    • 8.5.9 South East Asia Sales Analysis
    • 8.5.10 Rest Of Asia Pacific Sales Analysis
  • 8.6. Latin America Sales Analysis
    • 8.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.6.2 Latin America By Segment Sales Analysis
    • 8.6.3 Latin America By Country Sales Analysis
    • 8.6.4 Brazil Sales Analysis
    • 8.6.5 Argentina Sales Analysis
    • 8.6.6 Peru Sales Analysis
    • 8.6.7 Chile Sales Analysis
    • 8.6.8 Rest of Latin America Sales Analysis
  • 8.7. Middle East & Africa Sales Analysis
    • 8.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.7.2 Middle East & Africa By Segment Sales Analysis
    • 8.7.3 Middle East & Africa By Country Sales Analysis
    • 8.7.4 Saudi Arabia Sales Analysis
    • 8.7.5 UAE Sales Analysis
    • 8.7.6 Israel Sales Analysis
    • 8.7.7 South Africa Sales Analysis
    • 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE AUTOLOGOUS CELL THERAPY COMPANIES

  • 9.1. Autologous Cell Therapy Market Competition
  • 9.2. Partnership/Collaboration/Agreement
  • 9.3. Merger And Acquisitions
  • 9.4. New Product Launch
  • 9.5. Other Developments

10. COMPANY PROFILES OF AUTOLOGOUS CELL THERAPY INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Market Concentration Rate
  • 10.3. BrainStorm Cell Therapeutics
    • 10.3.1 Company Overview
    • 10.3.2 Company Revenue
    • 10.3.3 Products
    • 10.3.4 Recent Developments
  • 10.4. Holostem Terapie Avanzate S.R.L
    • 10.4.1 Company Overview
    • 10.4.2 Company Revenue
    • 10.4.3 Products
    • 10.4.4 Recent Developments
  • 10.5. Sartorius AG
    • 10.5.1 Company Overview
    • 10.5.2 Company Revenue
    • 10.5.3 Products
    • 10.5.4 Recent Developments
  • 10.6. Pharmicell Co. Inc
    • 10.6.1 Company Overview
    • 10.6.2 Company Revenue
    • 10.6.3 Products
    • 10.6.4 Recent Developments
  • 10.7. Opexa Therapeutics
    • 10.7.1 Company Overview
    • 10.7.2 Company Revenue
    • 10.7.3 Products
    • 10.7.4 Recent Developments
  • 10.8. Caladrius Biosciences Inc
    • 10.8.1 Company Overview
    • 10.8.2 Company Revenue
    • 10.8.3 Products
    • 10.8.4 Recent Developments
  • 10.9. U.S. Stem Cell Inc
    • 10.9.1 Company Overview
    • 10.9.2 Company Revenue
    • 10.9.3 Products
    • 10.9.4 Recent Developments
  • 10.10. Lonza
    • 10.10.1 Company Overview
    • 10.10.2 Company Revenue
    • 10.10.3 Products
    • 10.10.4 Recent Developments
  • 10.11. Bristol Myers Squibb
    • 10.11.1 Company Overview
    • 10.11.2 Company Revenue
    • 10.11.3 Products
    • 10.11.4 Recent Developments
  • 10.12. Novartis
    • 10.12.1 Company Overview
    • 10.12.2 Company Revenue
    • 10.12.3 Products
    • 10.12.4 Recent Developments
  • 10.13. Autolus Therapeutics
    • 10.13.1 Company Overview
    • 10.13.2 Company Revenue
    • 10.13.3 Products
    • 10.13.4 Recent Developments
  • 10.14. Tego Science
    • 10.14.1 Company Overview
    • 10.14.2 Company Revenue
    • 10.14.3 Products
    • 10.14.4 Recent Developments
  • 10.15. Corning Incorporated
    • 10.15.1 Company Overview
    • 10.15.2 Company Revenue
    • 10.15.3 Products
    • 10.15.4 Recent Developments
  • 10.16. Bio Elpida
    • 10.16.1 Company Overview
    • 10.16.2 Company Revenue
    • 10.16.3 Products
    • 10.16.4 Recent Developments
  • 10.17. Vericel Corporation
    • 10.17.1 Company Overview
    • 10.17.2 Company Revenue
    • 10.17.3 Products
    • 10.17.4 Recent Developments
  • 10.18. Catalent Inc
    • 10.18.1 Company Overview
    • 10.18.2 Company Revenue
    • 10.18.3 Products
    • 10.18.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies